Anna Pannaccione Selected Research

Anna Pannaccione Research Topics

Disease

9	Alzheimer Disease (Alzheimer's Disease) 02/2024 - 08/2012
7	Brain Ischemia (Cerebral Ischemia) 01/2019 - 01/2008
5	Neurodegenerative Diseases (Neurodegenerative Disease) 05/2024 - 01/2020
5	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2019 - 11/2009
4	Infarction (Infarctions) 08/2015 - 02/2008
3	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 05/2024 - 12/2022
3	Stroke (Strokes) 01/2019 - 01/2013
2	Dementia (Dementias) 02/2024 - 12/2022
1	Lysosomal Storage Diseases (Lysosomal Storage Disease) 05/2024
1	Cognitive Dysfunction 02/2024
1	Neuroinflammatory Diseases 01/2022
1	Insulin Resistance 01/2022
1	Central Nervous System Diseases (CNS Diseases) 01/2021
1	Schizophrenia (Dementia Praecox) 01/2019
1	Demyelinating Diseases (Demyelinating Disease) 01/2019
1	Seizures (Absence Seizure) 01/2019
1	Inflammation (Inflammations) 01/2019
1	Memory Disorders (Memory Loss) 01/2013
1	Hypoxia (Hypoxemia) 03/2009
1	Nervous System Diseases (Neurological Disorders) 04/2003

Drug/Important Bio-Agent (IBA)

5	Sodium-Calcium ExchangerIBA 03/2016 - 03/2009
4	Amyloid (Amyloid Fibrils)IBA 12/2023 - 01/2019
4	CalciumIBA 01/2022 - 02/2013
3	Protein Isoforms (Isoforms)IBA 05/2024 - 01/2013
3	Oxygen (Dioxygen)IBA 01/2019 - 02/2013
3	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 02/2013
2	beta-N-methylamino-L-alanine (beta-methylamino-L-alanine)IBA 02/2024 - 12/2022
2	NeurotoxinsIBA 02/2024 - 12/2022
2	Proteins (Proteins, Gene)FDA Link 12/2023 - 01/2008
2	Peptides (Polypeptides)IBA 01/2022 - 08/2012
2	IonsIBA 01/2021 - 02/2013
2	SodiumIBA 01/2020 - 02/2013
2	AntiportersIBA 01/2013 - 01/2013
2	sodium-calcium exchanger 1IBA 01/2013 - 11/2009
1	Transient Receptor Potential ChannelsIBA 05/2024
1	Two-Pore ChannelsIBA 05/2024
1	Lysergic Acid Diethylamide (LSD)IBA 05/2024
1	Particulate MatterIBA 02/2024
1	Glycerylphosphorylcholine (Choline Alfoscerate)IBA 02/2024
1	Cholinergic Agents (Cholinergics)IBA 02/2024
1	Monoterpenes (Monoterpenoids)IBA 01/2022
1	PolyphenolsIBA 01/2022
1	PhytochemicalsIBA 01/2022
1	Volatile Oils (Essential Oils)IBA 06/2021
1	Protective AgentsIBA 06/2021
1	Sodium Channels (Sodium Channel)IBA 01/2021
1	AcidsIBA 01/2021
1	Ion Channels (Ion Channel)IBA 01/2021
1	Voltage-Gated Sodium ChannelsIBA 01/2019
1	ORAI1 ProteinIBA 01/2019
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2019
1	D-Aspartic Acid (D Aspartate)IBA 01/2019
1	Calcium-Binding ProteinsIBA 03/2016
1	Calbindin 2IBA 03/2016
1	Dihydrotachysterol (AT 10)IBA 08/2015
1	5- amino- N- butyl- 2- (4- ethoxyphenoxy)- benzamide hydrochlorideIBA 08/2015
1	RE1-silencing transcription factorIBA 02/2013
1	Neuroprotective AgentsIBA 01/2013
1	7- nitro- 5- phenyl- 1- (pyrrolidin- 1- ylmethyl)- 1H- benzo(e)(1,4)diazepin- 2(3H)- oneIBA 01/2013
1	Carisoprodol (Soma)FDA LinkGeneric 11/2009
1	EstersIBA 11/2009
1	Fura-2 (Fura 2)IBA 11/2009
1	NF-kappa B (NF-kB)IBA 03/2009
1	OligodeoxyribonucleotidesIBA 02/2008
1	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2003

Therapy/Procedure

2	Therapeutics 05/2024 - 07/2020